全文获取类型
| 收费全文 | 10465篇 |
| 免费 | 714篇 |
| 国内免费 | 72篇 |
学科分类
| 医药卫生 | 11251篇 |
出版年
| 2024年 | 17篇 |
| 2023年 | 172篇 |
| 2022年 | 154篇 |
| 2021年 | 748篇 |
| 2020年 | 483篇 |
| 2019年 | 609篇 |
| 2018年 | 633篇 |
| 2017年 | 373篇 |
| 2016年 | 407篇 |
| 2015年 | 439篇 |
| 2014年 | 547篇 |
| 2013年 | 632篇 |
| 2012年 | 982篇 |
| 2011年 | 926篇 |
| 2010年 | 442篇 |
| 2009年 | 411篇 |
| 2008年 | 614篇 |
| 2007年 | 555篇 |
| 2006年 | 456篇 |
| 2005年 | 418篇 |
| 2004年 | 324篇 |
| 2003年 | 292篇 |
| 2002年 | 165篇 |
| 2001年 | 61篇 |
| 2000年 | 46篇 |
| 1999年 | 29篇 |
| 1998年 | 31篇 |
| 1997年 | 10篇 |
| 1996年 | 18篇 |
| 1995年 | 7篇 |
| 1994年 | 14篇 |
| 1993年 | 11篇 |
| 1992年 | 18篇 |
| 1991年 | 27篇 |
| 1990年 | 13篇 |
| 1989年 | 16篇 |
| 1988年 | 17篇 |
| 1987年 | 7篇 |
| 1986年 | 17篇 |
| 1985年 | 23篇 |
| 1984年 | 22篇 |
| 1983年 | 9篇 |
| 1982年 | 7篇 |
| 1981年 | 12篇 |
| 1979年 | 3篇 |
| 1978年 | 9篇 |
| 1977年 | 3篇 |
| 1976年 | 4篇 |
| 1972年 | 3篇 |
| 1967年 | 2篇 |
排序方式： 共有10000条查询结果，搜索用时 31 毫秒
1.
Syed M. Gilani Muhammad Khan Andrea Barbieri Manju L. Prasad 《Diagnostic Histopathology》2021,27(6):263-271
Anaplastic thyroid carcinoma (ATC) is an aggressive thyroid malignancy with high mortality rate. This malignancy arises in thyroid follicular cells either denovo or with an associated differentiated thyroid carcinoma component. Clinically, it usually presents as a rapidly enlarging mass, pain and locally compressive symptoms. Histopathologic variability and heterogeneity often pose diagnostic challenges, especially in scant and paucicellular specimens. This article describes the clinical, histopathologic and molecular features of ATC and also addresses the associated diagnostic limitations and challenges. 相似文献
2.
3.
4.
5.
6.
7.
Shafqat R. Chaudhry Ilana S. Lendvai Sajjad Muhammad Philipp Westhofen Johannes Kruppenbacher Lukas Scheef Henning Boecker Dirk Scheele Rene Hurlemann Thomas M. Kinfe 《Brain stimulation》2019,12(3):643-651
Objective
To assay peripheral inter-ictal cytokine serum levels and possible relations with non-invasive vagus nerve stimulation (nVNS) responsiveness in migraineurs.Methods
This double-blinded, sham-controlled study enrolled 48 subjects and measured headache severity, frequency [headache days/month, number of total and mild/moderate/severe classified attacks/month], functional state [sleep, mood, body weight, migraine-associated disability] and serum levels of inflammatory markers [inter-ictal] using enzyme-linked immunoassays at baseline and after 2 months of adjunctive nVNS compared to sham stimulation and suitably matched controls.Results
No significant differences were observed at baseline and after 2 months for headache severity, total attacks/month, headache days/month and functional outcome [sleep, mood, disability] between verum and sham nVNS. However, the number of severe attacks/month significantly decreased in the verum nVNS group and circulating pro-inflammatory IL-1β was elevated significantly in the sham group compared to nVNS. Levels of anti-inflammatory IL-10 were significantly higher at baseline in both groups compared to healthy controls, but not at 2 months follow-up [p?<?0.05]. Concentrations of high-mobility group box-1 (HMGB-1), IL-6, tumor-necrosis factor-α (TNF-α), leptin, adiponectin, ghrelin remained unchanged [p?>?0.05]. No severe device-/stimulation-related adverse events occurred.Conclusion
2 months of adjunctive cervical nVNS significantly declined the number of severe attacks/month. Pro-inflammatory IL-1β plasma levels [inter-ictal] were higher in sham-treated migraine patients compared to verum nVNS. However, pro- [IL-6, HMGB-1, TNF-α, leptin] and anti-inflammatory [IL-10, adiponectin, ghrelin] mediators did not differ statistically. Profiling of neuroinflammatory circuits in migraine to predict nVNS responsiveness remains an experimental approach, which may be biased by pre-analytic variables warranting large-scale biobank-based systematic investigations [omics]. 相似文献8.
van der Heijden Amber A. W. A. de Bruijne Martine C. Nijpels Giel Hugtenburg Jacqueline G. 《International journal of clinical pharmacy》2019,41(4):963-971
International Journal of Clinical Pharmacy - Background Drug-related problems (DRP) following hospital discharge may cause morbidity, mortality and hospital re-admissions. It is unclear whether a... 相似文献
9.
10.
